1. bookVolume 65 (2016): Edizione 1 (March 2016)
Dettagli della rivista
License
Formato
Rivista
eISSN
2544-4646
Prima pubblicazione
04 Mar 1952
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

Serotype-Specific Pneumococcal Status prior to PCV 13 Administration in Children and Adolescents with Inflammatory Bowel Disease

Dettagli della rivista
License
Formato
Rivista
eISSN
2544-4646
Prima pubblicazione
04 Mar 1952
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

Bamford A., P. Kelleher, H. Lyall, M. Haston, M. Zancolli, D. Goldblatt and B. Kampmann. 2014. Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection. AIDS 28: 2033–2243.10.1097/QAD.0000000000000385416601425222526 Search in Google Scholar

Centers for Disease Control and Prevention (CDC). 2013. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6–18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 62: 521–524. Search in Google Scholar

Concepcion N.F. and C.E. Frasch. 2001. Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 8: 266–272.10.1128/CDLI.8.2.266-272.20019604711238206 Search in Google Scholar

Frenck R.Jr., A. Thompson, S. Senders, L. Harris-Ford, M. Sperling, S. Patterson, C. Devlin, K.U. Jansen, W.C. Gruber, E.A. Emini and others. 2014. 13-Valent pneumococcal conjugate vaccine in older children and adolescents either previously immunized with or naïve to 7-valent pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 33: 183–189.10.1097/INF.000000000000005624136369 Search in Google Scholar

Levine A., S. Koletzko, D. Turner, J.C. Escher, S. Cucchiara, L. de Ridder, K.L. Kolho, G. Veres, R.K. Russell, A. Paerregaard and others. 2014. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J. Pediatr. Gastroenterol. Nutr. 58: 795–806.10.1097/MPG.000000000000023924231644 Search in Google Scholar

Rubin L.G., M.J. Levin, P. Ljungman, E.G. Davies, R. Avery, M. Tomblyn, A. Bousvaros, S. Dhanireddy, L. Sung, H. Keyserling and others. 2014. Infectious diseases society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin. Infect. Dis. 58:309–318. Search in Google Scholar

Skoczyńska A., A. Kuch, E. Sadowy, I. Waśko, M. Markowska, P. Ronkiewicz, B. Matynia, A. Bojarska, K. Wasiak, A. Gołębiewska and others. 2015. Participants of a laboratory-based surveillance of community acquired invasive bacterial infections (BINet). Recent trends in epidemiology of invasive pneumococcal disease in Poland. Eur. J. Clin. Microbiol. Infect. Dis. 34: 779–787.10.1007/s10096-014-2283-825475124 Search in Google Scholar

World Health Organisation (WHO). 2005. Pneumococcal conjugate vaccines. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Tech. Rep. Ser. 927 (Annex 2): 64–98. Search in Google Scholar

Wernette C.M., C.E. Frasch, D. Madore, G. Carlone, D. Goldblatt, B. Plikaytis, W. Benjamin, S.A. Quataert, S. Hildreth, D.J. Sikkema and others. 2003. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin. Diagn. Lab. Immunol. 10: 514–519.10.1128/CDLI.10.4.514-519.2003 Search in Google Scholar

Wysocki J., J. Brzostek, H. Szymański,B. Tetiurka, E. Toporowska-Kowalska, K. Wasowska-Królikowska, D.A. Sarkozy, P.C. Giardina, W.C. Gruber and others. 2015. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination. Vaccine 33: 1719–1725.10.1016/j.vaccine.2015.02.00525698485 Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo